{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:14:40Z","timestamp":1762161280694},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Cardiol Rep"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11886-017-0820-7","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T07:09:47Z","timestamp":1486624187000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Challenges with Evidence-Based Management of Stable Ischemic Heart Disease"],"prefix":"10.1007","volume":"19","author":[{"given":"Amit V.","family":"Patel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sripal","family":"Bangalore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,9]]},"reference":[{"issue":"38","key":"820_CR1","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1093\/eurheartj\/eht296","volume":"34","author":"G Montalescot","year":"2013","unstructured":"Montalescot G, Sechtem U, Achenbach S, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949\u20133003.","journal-title":"Eur Heart J"},{"issue":"4","key":"820_CR2","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIR.0000000000000152","volume":"131","author":"D Mozaffarian","year":"2015","unstructured":"Mozaffarian D, Benjamin EJ, Go AS, et al. Heart disease and stroke statistics\u20142015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29\u2013322.","journal-title":"Circulation"},{"key":"820_CR3","unstructured":"Statistics. NCfH. Mortality multiple cause micro-data files, 2011. Public-use data file and documentation. NHLBI tabulations. [cited Accessed July 3, 2014.]. Available from: http:\/\/www.cdc.gov\/nchs\/data_access\/Vitalstatsonline.htm - Mortality_."},{"issue":"2","key":"820_CR4","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1056\/NEJM199701093360203","volume":"336","author":"MA Hlatky","year":"1997","unstructured":"Hlatky MA, Rogers WJ, Johnstone I, et al. Medical care costs and quality of life after randomization to coronary angioplasty or coronary bypass surgery. Bypass Angioplasty Revascularization Investigation (BARI) Investigators. N Engl J Med. 1997;336(2):92\u20139.","journal-title":"N Engl J Med"},{"issue":"25","key":"820_CR5","doi-asserted-by":"crossref","first-page":"e354","DOI":"10.1161\/CIR.0b013e318277d6a0","volume":"126","author":"SD Fihn","year":"2012","unstructured":"Fihn SD, Gardin JM, Abrams J, et al. ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2012;126(25):e354\u2013471.","journal-title":"Circulation"},{"issue":"8922","key":"820_CR6","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0140-6736(94)91963-1","volume":"344","author":"S Yusuf","year":"1994","unstructured":"Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet. 1994;344(8922):563\u201370.","journal-title":"Lancet"},{"issue":"22","key":"820_CR7","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1161\/CIRCULATIONAHA.104.521864","volume":"111","author":"DG Katritsis","year":"2005","unstructured":"Katritsis DG, Ioannidis JP. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis. Circulation. 2005;111(22):2906\u201312.","journal-title":"Circulation"},{"issue":"15","key":"820_CR8","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1056\/NEJMoa070829","volume":"356","author":"WE Boden","year":"2007","unstructured":"Boden WE, O\u2019Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503\u201316.","journal-title":"N Engl J Med"},{"issue":"20","key":"820_CR9","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa1505532","volume":"373","author":"SP Sedlis","year":"2015","unstructured":"\u2022\u2022 Sedlis SP, Hartigan PM, Teo KK, et al. Effect of PCI on long-term survival in patients with stable ischemic heart disease. N Engl J Med. 2015;373(20):1937\u201346. This study provides long term follow up of the results from an important randomized strategy trial (COURAGE trial) demonstrating no difference in survival with follow up out to 15 years between PCI and OMT","journal-title":"N Engl J Med"},{"issue":"24","key":"820_CR10","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","volume":"360","author":"RL Frye","year":"2009","unstructured":"BARI 2D I, Frye RL, August P, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503\u201315.","journal-title":"N Engl J Med"},{"issue":"11","key":"820_CR11","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B De Bruyne","year":"2012","unstructured":"De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med. 2012;367(11):991\u20131001.","journal-title":"N Engl J Med"},{"issue":"13","key":"820_CR12","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1056\/NEJMoa1408758","volume":"371","author":"B De Bruyne","year":"2014","unstructured":"De Bruyne B, Fearon WF, Pijls NH, et al. Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med. 2014;371(13):1208\u201317.","journal-title":"N Engl J Med"},{"issue":"4","key":"820_CR13","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1161\/CIRCINTERVENTIONS.112.970954","volume":"5","author":"S Pursnani","year":"2012","unstructured":"Pursnani S, Korley F, Gopaul R, et al. Percutaneous coronary intervention versus optimal medical therapy in stable coronary artery disease: a systematic review and meta-analysis of randomized clinical trials. Circulation Cardiovascular Interventions. 2012;5(4):476\u201390.","journal-title":"Circulation Cardiovascular Interventions"},{"issue":"7","key":"820_CR14","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1161\/CIRCULATIONAHA.112.131961","volume":"127","author":"S Bangalore","year":"2013","unstructured":"Bangalore S, Pursnani S, Kumar S, et al. Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease. Circulation. 2013;127(7):769\u201381.","journal-title":"Circulation"},{"issue":"6","key":"820_CR15","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.ahj.2013.09.008","volume":"166","author":"S Bangalore","year":"2013","unstructured":"Bangalore S, Pencina MJ, Kleiman NS, et al. Prognostic implications of procedural vs spontaneous myocardial infarction: results from the Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry. Am Heart J. 2013;166(6):1027\u201334.","journal-title":"Am Heart J"},{"issue":"5","key":"820_CR16","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1161\/01.CIR.82.5.1647","volume":"82","author":"WJ Rogers","year":"1990","unstructured":"Rogers WJ, Coggin CJ, Gersh BJ, et al. Ten-year follow-up of quality of life in patients randomized to receive medical therapy or coronary artery bypass graft surgery. The Coronary Artery Surgery Study (CASS). Circulation. 1990;82(5):1647\u201358.","journal-title":"Circulation"},{"issue":"5","key":"820_CR17","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.68.5.939","volume":"68","author":"Coronary artery surgery study (CASS)","year":"1983","unstructured":"Coronary artery surgery study (CASS). A randomized trial of coronary artery bypass surgery. Circulation. 1983;68(5):939\u201350.","journal-title":"Circulation"},{"issue":"7","key":"820_CR18","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0735-1097(03)00951-3","volume":"42","author":"RA Henderson","year":"2003","unstructured":"Henderson RA, Pocock SJ, Clayton TC, et al. Seven-year outcome in the RITA-2 trial: coronary angioplasty versus medical therapy. J Am Coll Cardiol. 2003;42(7):1161\u201370.","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"820_CR19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1056\/NEJMoa072771","volume":"359","author":"WS Weintraub","year":"2008","unstructured":"Weintraub WS, Spertus JA, Kolm P, et al. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008;359(7):677\u201387.","journal-title":"N Engl J Med"},{"issue":"14","key":"820_CR20","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1161\/CIRCULATIONAHA.110.978247","volume":"123","author":"GR Dagenais","year":"2011","unstructured":"Dagenais GR, Lu J, Faxon DP, et al. Effects of optimal medical treatment with or without coronary revascularization on angina and subsequent revascularizations in patients with type 2 diabetes mellitus and stable ischemic heart disease. Circulation. 2011;123(14):1492\u2013500.","journal-title":"Circulation"},{"issue":"14","key":"820_CR21","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","volume":"131","author":"J Iqbal","year":"2015","unstructured":"Iqbal J, Zhang YJ, Holmes DR, et al. Optimal medical therapy improves clinical outcomes in patients undergoing revascularization with percutaneous coronary intervention or coronary artery bypass grafting: insights from the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial at the 5-year follow-up. Circulation. 2015;131(14):1269\u201377.","journal-title":"Circulation"},{"issue":"10","key":"820_CR22","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.jacc.2016.06.020","volume":"68","author":"S Bangalore","year":"2016","unstructured":"Bangalore S. Applicability of the COURAGE, BARI-2D, and FREEDOM trials to contemporary practice. J Am Coll Cardiol. 2016;68(10):996\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"820_CR23","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.2015.11219","volume":"314","author":"S Bangalore","year":"2015","unstructured":"Bangalore S, Maron DJ, Hochman JS. Evidence-based management of stable ischemic heart disease: challenges and confusion. JAMA. 2015;314(18):1917\u20138.","journal-title":"JAMA"},{"issue":"20","key":"820_CR24","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.jacc.2013.02.011","volume":"61","author":"M Kosiborod","year":"2013","unstructured":"Kosiborod M, Arnold SV, Spertus JA, et al. Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol. 2013;61(20):2038\u201345.","journal-title":"J Am Coll Cardiol"},{"key":"820_CR25","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-015-0358-8","volume":"13","author":"XL Zhang","year":"2015","unstructured":"Zhang XL, Zhu QQ, Zhu L, et al. Safety and efficacy of anti-PCSK9 antibodies: a meta-analysis of 25 randomized, controlled trials. BMC Medicine. 2015;13:123.","journal-title":"BMC Medicine"},{"issue":"7","key":"820_CR26","volume":"8","author":"R Waksman","year":"2015","unstructured":"Waksman R, Maya J, Angiolillo DJ, et al. Ticagrelor versus clopidogrel in black patients with stable coronary artery disease: prospective, randomized, open-label, multiple-dose. Crossover Pilot Study Circulation Cardiovascular Interventions. 2015;8(7):e002232.","journal-title":"Crossover Pilot Study Circulation Cardiovascular Interventions"},{"issue":"3","key":"820_CR27","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jcin.2015.10.036","volume":"9","author":"W Hochholzer","year":"2016","unstructured":"Hochholzer W, Amann M, Titov A, et al. Randomized comparison of different thienopyridine loading strategies in patients undergoing elective coronary intervention: the ExcelsiorLOAD Trial. JACC Cardiovascular Interventions. 2016;9(3):219\u201327.","journal-title":"JACC Cardiovascular Interventions"},{"issue":"22","key":"820_CR28","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","volume":"373","author":"B Zinman","year":"2015","unstructured":"Zinman B, Wanner C, Lachin JM, et al. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med. 2015;373(22):2117\u201328.","journal-title":"N Engl J Med"},{"issue":"4","key":"820_CR29","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"issue":"25","key":"820_CR30","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","volume":"372","author":"CP Cannon","year":"2015","unstructured":"Cannon CP, Blazing MA, Giugliano RP, et al. Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med. 2015;372(25):2387\u201397.","journal-title":"N Engl J Med"},{"issue":"22","key":"820_CR31","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","volume":"373","author":"JT Wright Jr","year":"2015","unstructured":"Group SR, Wright Jr JT, Williamson JD, et al. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015;373(22):2103\u201316.","journal-title":"N Engl J Med"},{"key":"820_CR32","doi-asserted-by":"crossref","first-page":"f6625","DOI":"10.1136\/bmj.f6625","volume":"347","author":"S Bangalore","year":"2013","unstructured":"Bangalore S, Toklu B, Amoroso N, et al. Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis. BMJ. 2013;347:f6625.","journal-title":"BMJ"},{"issue":"3","key":"820_CR33","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa0807611","volume":"360","author":"PA Tonino","year":"2009","unstructured":"Tonino PA, De Bruyne B, Pijls NH, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med. 2009;360(3):213\u201324.","journal-title":"N Engl J Med"},{"issue":"10","key":"820_CR34","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1056\/NEJMoa0804626","volume":"360","author":"PW Serruys","year":"2009","unstructured":"Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961\u201372.","journal-title":"N Engl J Med"},{"issue":"1","key":"820_CR35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1161\/CIRCINTERVENTIONS.112.000126","volume":"6","author":"S Bangalore","year":"2013","unstructured":"Bangalore S. Complete revascularization in contemporary practice. Circulation Cardiovascular Interventions. 2013;6(1):5\u20137.","journal-title":"Circulation Cardiovascular Interventions"},{"key":"820_CR36","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1056\/NEJMoa1412168","volume":"372","author":"S Bangalore","year":"2015","unstructured":"\u2022\u2022 Bangalore S, Guo Y, Samadashvili Z, et al. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. N Engl J Med. 2015;372:1213\u201322. This study demonstrates that there is no difference in death between use of contemporary drug eluting stents and CABG","journal-title":"N Engl J Med"},{"issue":"22","key":"820_CR37","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.115.021168","volume":"133","author":"S Bangalore","year":"2016","unstructured":"Bangalore S, Guo Y, Samadashvili Z, et al. Revascularization in patients with multivessel coronary artery disease and severe left ventricular systolic dysfunction: everolimus-eluting stents versus coronary artery bypass graft surgery. Circulation. 2016;133(22):2132\u201340.","journal-title":"Circulation"},{"issue":"9962","key":"820_CR38","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","volume":"385","author":"PW Serruys","year":"2015","unstructured":"Serruys PW, Chevalier B, Dudek D, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet. 2015;385(9962):43\u201354.","journal-title":"Lancet"},{"issue":"2","key":"820_CR39","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jtcvs.2016.03.089","volume":"152","author":"C Locker","year":"2016","unstructured":"Locker C, Schaff HV, Daly RC, et al. Multiple arterial grafts improve survival with coronary artery bypass graft surgery versus conventional coronary artery bypass grafting compared with percutaneous coronary interventions. J Thorac Cardiovasc Surg. 2016;152(2):369\u201379. e4","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"820_CR40","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ahj.2013.07.007","volume":"166","author":"GB Mancini","year":"2013","unstructured":"Mancini GB, Hartigan PM, Bates ER, et al. Prognostic importance of coronary anatomy and left ventricular ejection fraction despite optimal therapy: assessment of residual risk in the Clinical Outcomes Utilizing Revascularization and Aggressive DruG Evaluation Trial. Am Heart J. 2013;166(3):481\u20137.","journal-title":"Am Heart J"},{"issue":"6","key":"820_CR41","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.nuclcard.2006.08.017","volume":"13","author":"R Hachamovitch","year":"2006","unstructured":"Hachamovitch R, Rozanski A, Hayes SW, et al. Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary? Journal of Nuclear Cardiology Official Publication of the American Society of Nuclear Cardiology. 2006;13(6):768\u201378.","journal-title":"Journal of Nuclear Cardiology Official Publication of the American Society of Nuclear Cardiology"}],"container-title":["Current Cardiology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11886-017-0820-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11886-017-0820-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T10:09:16Z","timestamp":1498385356000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11886-017-0820-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["820"],"URL":"https:\/\/doi.org\/10.1007\/s11886-017-0820-7","relation":{},"ISSN":["1523-3782","1534-3170"],"issn-type":[{"value":"1523-3782","type":"print"},{"value":"1534-3170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"article-number":"11"}}